Navigation Links
Clinical Trial Shows Cardiovascular Benefits of Rooibos, Popular Antioxidant Herbal Tea from South Africa
Date:9/10/2008

AUSTIN, Texas, Sept. 10 /PRNewswire-USNewswire/ -- The first-ever human clinical trial on a popular traditional South African herbal tea was recently conducted, testing whether the tea can possibly lower the risk of cardiovascular disease.

The new trial also generated the first human safety data in a controlled clinical trial environment, scientifically showing that short-term consumption of rooibos tea is safe for the liver and kidneys while keeping various blood parameters (e.g., blood pressure, cholesterol levels, etc.) in a normal range.(1)

Provisional results from this study indicate that rooibos tea protects the body against oxidative damage, as seen by the approximate 21% decrease in conjugated dienes in the blood. Conjugated dienes are products formed in large numbers during the early stages of oxidation (destruction) of important cellular components such as fats (lipids). These lipid peroxidation products may be implicated in the development of vascular disease.

The trial (entitled "Modulation of blood oxidative stress markers and DNA damage by rooibos tea in volunteers at risk for coronary heart disease") was conducted by Jeanine L. Marnewick, Ph.D., senior researcher at the Oxidative Stress Research Centre at Cape Peninsula University of Technology in Cape Town, South Africa.

The trial was conducted on 40 individuals (males and females), between the ages of 30 and 60, from the Western Cape Province with any two or more of the following cardiovascular disease risk factors: hyperlipidemia (high cholesterol), hypertension (high blood pressure), smoking, and/or increased body mass index (BMI: 25 or higher), but not requiring any oral medication for these medical conditions. The actual risk of each participant was determined using a calculation based on the famous multi-year Framingham heart disease trial based on the patient's age, gender, smoking status, blood pressure, triglycerides and HDL cholesterol (so-called "good cho
'/>"/>

SOURCE American Botanical Council
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. China Sky One Medical, Inc. Announces 26 New Drugs in Clinical Trials
2. Circassia Achieves Successful Phase II Clinical Results With Toleromune(R) Anti-Allergy Technology
3. Alpharma Announces Positive Results From Pivotal Phase III Efficacy Trial on ALO-01 (EMBEDA(TM)) (morphine sulfate extended-release with sequestered naltrexone hydrochloride) Capsules at the American Academy of Pain Management Annual Clinical Meeting
4. Epiphany Biosciences to Continue Phase 2 Shingles Study After Interim Analysis; Plans Follow-On Clinical Trial Studying Post-Herpetic Neuralgia (PHN)
5. FluoroPharma, Inc. to Report Preclinical Data on Alzheimers Disease and Prostate Cancer PET Imaging Agents
6. Novo Nordisk New Data From a Phase 3 Study Confirms Clinical Benefits of Once-Daily Liraglutide in the Management of Type 2 Diabetes
7. SARcode and Sunesis Announce Start of Phase 1 Clinical Trial in Ocular Inflammatory Diseases
8. Cystic Fibrosis Axentis Pharma Initiates Clinical Trial for Lung Infections
9. Aegerion Pharmaceuticals, Inc. adds Peter Garrambone to Board of Directors, Secures Additional Capital for Clinical Trials
10. Simcere Pharmaceutical Group Announces Interim Results of Endu Phase IV Clinical Study
11. Diffusion Pharmaceuticals Announces Initiation of a Phase I/II Clinical Trial in Patients with Peripheral Arterial Disease (PAD)

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)...aceuticalInstitute,aleadingproviderofspecializedtr...try,todayannouncedthelaunchofanewe-coursetitled, H...ourseisthenewestadditiontothecompany,s ManagedMark...oursesdesignedtofillthecriticalneedforbasicandadva...als. ,, Thenewthreemodule HospitalMarketplace e...
(Date:11/24/2009)...ciencesCorporationannouncedtodaythattherewillbemul...rationFLT3inhibitor,inAMLatthe51stAmericanSocietyo...LA,December5-8,2009.Anoralpresentationwillhighligh...tystudyinadultswithacutemyeloidleukemia(AML).Addit...heeffectofAC220monotherapyandincombinationwithchem...
(Date:11/24/2009)...uifengBio-Pharmaceutical,Technology,Inc.(OTCBullet...extractsandpharmaceuticalrawmaterialsforuseinpharm...hina,todayreportedthatinits,thirdquarter,thecompan...rthequarterendedSept.30,2009were$4,465,770,anincre...erin2008.Netincome,amountedto1,002,005,or$0.05pers...
Breaking Medicine Technology:Pharmaceutical Institute Launches New Training Resource Focused on the Hospital Marketplace 2Ambit Biosciences Corporation Announces Presentations Profiling AC220 Clinical and Non-Clinical Data at 51st American Society of Hematology Annual Meeting 2Ambit Biosciences Corporation Announces Presentations Profiling AC220 Clinical and Non-Clinical Data at 51st American Society of Hematology Annual Meeting 3Huifeng Bio-Pharmaceutical Technology Reports 26% Quarterly Revenue Increase 2Huifeng Bio-Pharmaceutical Technology Reports 26% Quarterly Revenue Increase 3Connectyx Technologies Holdings Group Inc to Host Nationwide Teleconference Today July 9 2009 3B Company Will Discuss Recent Developments New Par 51216 1Connectyx Technologies Holdings Group Inc to Host Nationwide Teleconference Today July 9 2009 3B Company Will Discuss Recent Developments New Par 51216 2Walmart Foundation Commits 24500 000 to Improving Emergency Preparedness for the 54 Million Americans with Disabilities 51211 1Walmart Foundation Commits 24500 000 to Improving Emergency Preparedness for the 54 Million Americans with Disabilities 51211 2Walmart Foundation Commits 24500 000 to Improving Emergency Preparedness for the 54 Million Americans with Disabilities 51211 3ICU Medical Inc to Acquire Hospiras Critical Care Product Line 51206 1ICU Medical Inc to Acquire Hospiras Critical Care Product Line 51206 2ICU Medical Inc to Acquire Hospiras Critical Care Product Line 51206 3ICU Medical Inc to Acquire Hospiras Critical Care Product Line 51206 4ICU Medical Inc to Acquire Hospiras Critical Care Product Line 51206 5
(Date:11/24/2009)...ool of Medicine compared the outcomes of cirrhotic...lcoholic steatohepatitis (NASH) versus alcoholic l...nificant differences in post-transplant survival r...ngs are presented in the December issue of Liver ...ckwell on behalf of the American Association for t...
(Date:11/24/2009)...ewswire/--EnigmaDiagnosticsLimited,thedecentralise...ncedtodayfourseniorappointmentsforitsUSandEuropean...esidentandCEOwithGregHamilton,ChiefOperatingOffice...ewU.S.headquartersinSanDiego,California,theheadqua...nnedforassaydevelopment,R&Dandcommercialactivi...
(Date:11/24/2009)...ire/--SkyFoundation,Inc.,anon-profitfoundationdedi...dtestfortheearlydetectionofpancreaticcancer,todaya...oninJune2008.TheannouncementwasmadebySheilaSkyKass...firstmajorfundraiser. ,, Thefoundationhelditsfi...eClubinBloomfieldHills,Mich.Guestsheardfromspeaker...
(Date:11/24/2009)...SNewswire/--Parties,familydinners,andothergatherin...themerrimentcanchangetomiseryiffoodmakesyouorother...prnh/20090824/FDALOGO ) ,, Typicalsymptomsoffoo...oms,whichcanstartanywherefromhourstodaysafterconta...isthatpracticingfourbasicfoodsafetymeasurescanhelp...
(Date:11/24/2009)...ntros,aleadinghealthcareanalyticsanddecisionsuppor...aslicensedintellectualpropertyandassociatedsoftwar...ntoQuantros,suiteofsafetyandriskmanagement(SRM)pro...SRMproductfamilywillenableautomatedsafetydataanaly...hcareprovider,sintegratedadministrativedata.Thesen...
Breaking Medicine News(10 mins):Health News:New data emerges on liver transplant survival rates 2Health News:New data emerges on liver transplant survival rates 3Health News:Enigma Diagnostics Expands Its US and European Executive Management Teams 2Health News:Enigma Diagnostics Expands Its US and European Executive Management Teams 3Health News:Sky Foundation, Inc. Raises More Than $100,000 to Find a Test for Early Detection of Pancreatic Cancer 2Health News:FDA Consumer Health Information: Food Safety Tips for Healthy Holidays 2Health News:Quantros Licenses Adverse Event Identification Technology from University of Michigan 2
...-PRNewswire/ -- Chindex International,(Nasdaq: CH...named as a,finalist for the Ernst & Young Entrepre...ington Region. According to Ernst & Young LLP, the...nt to,their businesses and communities. Lipson was...
...Adult Acne Sufferers, LOS ANGELES, May 22 While ...e of passage," results from a groundbreaking,natio...lem that also,commonly affects adults. The survey ...may be preventing or hindering,appropriate treatme...
...icans Living with or at Risk for,Osteoporosis, Con...porosis,is Lacking, WASHINGTON, May 22 The Natio...results of a nationwide survey that,reveals a conc... bone health between patients in this age group an...
...French . , , Montreal, May 22, 2008 Expectant m...uring their first trimester, according to a new st... Hospital published in the May edition of the Brit...o investigate the impact of antidepressant use dur...
... Ontario implements a ban on the retail display of...io Tobacco Research Unit at the University of Toro...tensive tobacco promotion at point of sale. , Pla...h large tobacco product displays, countertop displ...
...rs Former CEO with Permanent Legacy at ...22 GlaxoSmithKline (NYSE:,GSK) today announced th...00,in honor of former Chief Executive Officer Jean...n from the school in 1974,retired from GSK on May ...
Other Medicine News:Health News:Chindex International, CEO, Roberta Lipson Named Ernst & Young Entrepreneur Of The Year(R) 2008 Award Finalist in Greater Washington 2Health News:Chindex International, CEO, Roberta Lipson Named Ernst & Young Entrepreneur Of The Year(R) 2008 Award Finalist in Greater Washington 3Health News:Acne - Not Just a Teen Issue 2Health News:Acne - Not Just a Teen Issue 3Health News:Acne - Not Just a Teen Issue 4Health News:Acne - Not Just a Teen Issue 5Health News:Acne - Not Just a Teen Issue 6Health News:National Osteoporosis Foundation Survey Reveals Low Awareness of Bone Health and Risk of Osteoporosis 2Health News:National Osteoporosis Foundation Survey Reveals Low Awareness of Bone Health and Risk of Osteoporosis 3Health News:GlaxoSmithKline Announces $500,000 in Fellowships at Stanford Graduate School of Business 2Health News:GlaxoSmithKline Announces $500,000 in Fellowships at Stanford Graduate School of Business 3
...ratories is a national reference laboratory and a ... and development. ARUP offers an extensive test me...linical and anatomic pathology. Owned by the Unive...more than half of the nation's university teaching...
...ratories is a national reference laboratory and a ... and development. ARUP offers an extensive test me...linical and anatomic pathology. Owned by the Unive...more than half of the nation's university teaching...
...ratories is a national reference laboratory and a ... and development. ARUP offers an extensive test me...linical and anatomic pathology. Owned by the Unive...more than half of the nation's university teaching...
...ratories is a national reference laboratory and a ... and development. ARUP offers an extensive test me...linical and anatomic pathology. Owned by the Unive...more than half of the nation's university teaching...
Medicine Products: